PEGylated PAMAM Dendrimer-Doxorubicin Conjugates: In Vitro Evaluation and In Vivo Tumor Accumulation

By Zhu Saijie   Hong Minghuang   Zhang Lihong   Tang Guotao   Jiang Yanyan   Pei Yuanying  

Pharmaceutical Research, Vol. 27, Iss. 1, 2010-01 ,pp. : 161-174

Springer Publishing Company

Access to resources Recommend Favorite

Decreased Activity and Expression of Intestinal Oligopeptide Transporter PEPT1 in Rats with Hyperthyroidism In Vivo

By Ashida Kayoko   Katsura Toshiya   Saito Hideyuki   Inui Ken-ichi  

Pharmaceutical Research, Vol. 21, Iss. 6, 2004-06 ,pp. : 969-975

Springer Publishing Company

Access to resources Recommend Favorite

An In Vivo Approach to Structure Activity Relationship Analysis of Peptide Ligands

By Fan Xiaomin   Venegas Ruben   Fey Robert   Heyde Henri   Bernard Mark   Lazarides Elias   Woods Catherine  

Pharmaceutical Research, Vol. 24, Iss. 5, 2007-05 ,pp. : 868-879

Springer Publishing Company

Access to resources Recommend Favorite

In Vitro and in Vivo Metabolism of the Anti-Cancer Agent CI-1040, a MEK Inhibitor, in Rat, Monkey, and Human

By Wabnitz Paul A.   Mitchell David   Wabnitz David A.M.  

Pharmaceutical Research, Vol. 21, Iss. 9, 2004-09 ,pp. : 1670-1679

Springer Publishing Company

Access to resources Recommend Favorite

Dosage Form Development, in Vitro Release Kinetics, and in Vitro–in Vivo Correlation for Leuprolide Released from an Implantable Multi-reservoir Array

By Prescott James   Krieger Timothy   Lipka Sara   Staples Mark  

Pharmaceutical Research, Vol. 24, Iss. 7, 2007-07 ,pp. : 1252-1261

Springer Publishing Company

Access to resources Recommend Favorite